Hi,
Alzheimer’s disease mostly occurs after 60 yrs. Your symptoms of
dementiaAlzheimer’s disease
Dementia
Multi-infarct dementia
Pick’s disease could be due to stress . But the possibility of early symptoms of the disease cannot be overruled .
While there is no cure for Alzheimer's disease and no proven treatment to slow its progression, there are a number of medicines available that may help improve the
mentalMental retardation
Mental status tests function of people with Alzheimer's disease. If these medications are given early enough in the course of the disease, the drugs may enable people to carry out their
dailyDaily combo
Daily multiple for men 50+
Daily multiple for women
Daily multiple for women 50+
Daily multiple vitamins
Daily vite
Daily-vite men's formula
Daily-vite weight control activities and independent
livingAdvanced care directives for a longer period of time and may prolong the time that patients can be managed at home. There are also medicines available to help manage some of the most troubling symptoms of Alzheimer's disease, including depression and behavioral problems such as agitation and aggression.Some of the medicines are – Aricept , Exelon and Razadyne , Namenda and Cognex .
Although there is no cure for Alzheimer's disease, planning and medical/social management can help ease the burden on both patients and family members. Exercise, good nutrition, activities, and social interaction are important. A calm, structured environment also may help the person with Alzheimer's disease to continue functioning as long as possible. Please consult a neurologist to find out whether your symptoms are of The early stage of the disease and know the management plan . Hope this helps you . Take care and regards !
Thanx a lot ! Yes , Rember is an investigational drug being developed by TauRx Therapeutics that has been shown in early clinical trials to be an inhibitor of Tau protein aggregation.One active ingredient is methylthioninium chloride (MTC), a form of methylene blue.The drug is of potential interest for the treatment of patients with Alzheimer's disease. TauRx Therapeutics has suggested that the mechanism by which methylene blue might delay or reverse neurodegeneration in Alzheimer's disease is as an inhibitor of Tau protein aggregation. While methylene blue arguably has an effect on Tau aggregation, it also has an effect on mitochondrial function which is likely to play an important role. Studies suggest that methylene blue might be an effective remedy for both Alzheimer's and Parkinson's disease by enhancing key mitochondrial biochemical pathways.